UCSF Pharmacogenetics of Membrane Transporters
Snp Publications
PMT SNP UID:2868
  1. Takayoshi K, Sagara K, Uchino K, Kusaba H, Sakamoto N, Iguchi A, Baba E. A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine. BMC Cancer. 2015 May 22;15(1):426. PMID: 26001650.
  2. Wang YX, Li JL, Wang XD, Zhang Y, Wang CX, Huang M. Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation. Acta Pharmacol Sin. 2015 Apr 20. PMID: 25891084.
  3. Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies AT. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. Clin Pharmacokinet. 2015 Apr 10. PMID: 25860377.
  4. Breitenstein B, Brückl TM, Ising M, Müller-Myhsok B, Holsboer F, Czamara D. ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2015 Apr 2. PMID: 25847751.
  5. Kim MG, Kim IW, Choi B, Han N, Yun HY, Park S, Oh JM. Population Pharmacokinetics of Cyclosporine in Hematopoietic Stem Cell Transplant Patients: Consideration of Genetic Polymorphisms. Ann Pharmacother. 2015 Mar 27. PMID: 25818517.
  6. Lambrechts S, Lambrechts D, Despierre E, Van Nieuwenhuysen E, Smeets D, Debruyne PR, Renard V, Vroman P, Luyten D, Neven P, Amant F, Leunen K, Vergote I, Belgian and Luxembourg Gynaecological Oncology Group (BGOG). Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC Pharmacol Toxicol. 2015 Feb 27;16(1):2. PMID: 25881102.
  7. He H, Yin J, Li X, Zhang Y, Xu X, Zhai M, Chen J, Qian C, Zhou H, Liu Z. Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia. Eur J Clin Pharmacol. 2015 Jan 9. PMID: 25567217.
  8. Robertsen I, Vethe NT, Midtvedt K, Falck P, Christensen H, Åsberg A. Closer to the site of action; everolimus concentrations in peripheral blood mononuclear cells correlate well with whole blood concentrations. Ther Drug Monit. 2015 Jan 6. PMID: 25565673.
  9. Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MÁ, Aliño SF. Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies. Pharmacogenomics J. 2015 Jan 6. PMID: 25558979.
  10. Pongstaporn W, Pakakasama S, Chaksangchaichote P, Pongtheerat T, Hongeng S, Permitr S. MDR1 C3435T and C1236T Polymorphisms: Association with High-risk Childhood Acute Lymphoblastic Leukemia. Asian Pac J Cancer Prev. 2015;16(7):2839-43. PMID: 25854371.
  11. Li H, Wang B, Chang C, Wu M, Xu Y, Jiang Y. The Roles of Variants in Human Multidrug Resistance (MDR1) Gene and Their Haplotypes on Antiepileptic Drugs Response: A Meta-Analysis of 57 Studies. PLoS One. 2015;10(3):e0122043. PMID: 25816099.
  12. Zhou Z, Chen Q, Zuo D, Wang H, Hua Y, Cai Z. ABCB1 (rs1128503) polymorphism and response to chemotherapy in patients with malignant tumors-evidences from a meta-analysis. Int J Clin Exp Med. 2015;8(1):265-72. PMID: 25784996.
  13. Cao Y, Qu C, Chen Y, Li L, Wang X. Association of abcb1 polymorphisms and ulcerative colitis susceptibility. Int J Clin Exp Pathol. 2015;8(1):943-7. PMID: 25755800.
  14. Saidijam M, Mahjub H, Shabab N, Yadegarazari R. Simultaneous Analysis of Multidrug Resistance 1(MDR1) C3435T, G2677T/A, and C1236T Genotypes in Hamadan City Population, West of Iran. Iran Biomed J. 2015 Jan;19(1):57-62. PMID: 25605491.
  15. Ma L, Liu H, Ruan L, Yang X, Yang H, Feng Y. Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: A meta-analysis. Biomed Rep. 2015 Jan;3(1):83-87. PMID: 25469253.
  16. Choi JR, Kim JO, Kang DR, Shin JY, Zhang XH, Oh JE, Park JY, Kim KA, Kang JH. Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel Chemotherapy. Cancer Res Treat. 2014 Dec 16. PMID: 25648089.
  17. Peñas-Lledó E, Guillaume S, Delgado A, Naranjo ME, Jaussent I, LLerena A, Courtet P. ABCB1 gene polymorphisms and violent suicide attempt among survivors. J Psychiatr Res. 2014 Dec 15. PMID: 25543520.
  18. Kobayashi H, Sato K, Niioka T, Miura H, Ito H, Miura M. Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2014 Dec 11. PMID: 25554506.
  19. Koo DH, Ryu MH, Ryoo BY, Beck MY, Na YS, Shin JG, Lee SS, Kim EY, Kang YK. Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor. Cancer Chemother Pharmacol. 2014 Nov 23. PMID: 25417047.
  20. Ali MA, Elsalakawy WA. ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate. Med Oncol. 2014 Nov;31(11):279. PMID: 25301112.
  21. Yang QF, Chen BL, Zhang QS, Zhu ZH, Hu B, He Y, Gao X, Wang YM, Hu PJ, Chen MH, Zeng ZR. Contribution of MDR1 gene polymorphisms on IBD predisposition and response to glucocorticoids in IBD in Chinese population. J Dig Dis. 2014 Oct 27. PMID: 25346426.
  22. Mei Y, Wang SY, Li Y, Yi SQ, Wang CY, Yang M, Duan KM. The role of SLCO1B1, ABCB1 and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients. J Clin Pharmacol. 2014 Oct 3. PMID: 25279974.
  23. Fehér A, Juhász A, Pákáski M, Kálmán J, Janka Z. ABCB1 C3435T Polymorphism Influences the Risk for Alzheimer's Disease. J Mol Neurosci. 2014 Oct 2. PMID: 25273678.
  24. Zheng Q, Wu H, Yu Q, Kim DH, Lipton JH, Angelini S, Soverini S, Vivona D, Takahashi N, Cao J. ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis. Pharmacogenomics J. 2014 Sep 23. PMID: 25245580.
  25. Martinelli M, Scapoli L, Cura F, Rodia MT, Ugolini G, Montroni I, Solmi R. Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms. J Biomed Sci. 2014 Sep 4;21(1):89. PMID: 25355168.
  26. Saracino A, Muscaridola N, Cifarelli RA, Stallone G, Grandaliano G, Santarsia G. Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation. Transplant Proc. 2014 Sep;46(7):2214-9. PMID: 25242754.
  27. Weissfeld JL, Diergaarde B, Nukui T, Buch S, Pennathur A, Socinski MA, Siegfried JM, Romkes M. Inherited Variation in the ATP-Binding Cassette Transporter ABCB1 and Survival after Chemotherapy for Stage III-IV Lung Cancer. J Thorac Oncol. 2014 Sep;9(9):1264-71. PMID: 25122423.
  28. DiDomenico RJ, Bress AP, Na-Thalang K, Tsao YY, Groo VL, Deyo KL, Patel SR, Bishop JR, Bauman JL. Use of a Simplified Nomogram to Individualize Digoxin Dosing versus Standard Dosing Practices in Patients with Heart Failure. Pharmacotherapy. 2014 Aug 28. PMID: 25164709.
  29. Jakobsen Falk I, Fyrberg A, Paul E, Nahi H, Hermanson M, Rosenquist R, Höglund M, Palmqvist L, Stockelberg D, Wei Y, Gréen H, Lotfi K. Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype. Br J Haematol. 2014 Aug 23. PMID: 25155901.
  30. Kim KA, Cha YJ, Lee HM, Joo HJ, Park JY. Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans. Clin Chim Acta. 2014 Aug 11. PMID: 25124867.
  31. Yaya K, Hind D, Meryem Q, Asma Q, Said B, Sellama N. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia. Tumour Biol. 2014 Aug 5. PMID: 25087925.
  32. Zgheib NK, Akra-Ismail M, Aridi C, Mahfouz R, Abboud MR, Solh H, Muwakkit SA. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014 Aug;24(8):387-96. PMID: 25007187.
  33. Dizdarevic S, Aplin M, Newport MJ, Ryan N, Holt S, Goubet S, Goldberg L, Miles KA, Peters AM. Old tracer for a new purpose: potential role for 99mTc-2-methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant care. Nucl Med Commun. 2014 Jul 14. PMID: 25025147.
  34. Liu S, Yi Z, Ling M, Shi J, Qiu Y, Yang S. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy. Tumour Biol. 2014 Jul 5. PMID: 24996541.
  35. Cortejoso L, García MI, García-Alfonso P, Grávalos C, Robles L, González-Haba E, Sanjurjo M, López-Fernández LA. [Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients]. Farm Hosp. 2014 Jul 1;38(4):283-90. PMID: 25137161.
  36. Takakuwa O, Oguri T, Uemura T, Kunii E, Nakao M, Hijikata H, Kawaguchi Y, Ohkubo H, Takemura M, Maeno K, Niimi A. ABCB1 Polymorphism as a Predictive Biomarker for Amrubicin-induced Neutropenia. Anticancer Res. 2014 Jul;34(7):3517-22. PMID: 24982363.
  37. Vasilopoulos Y, Sarri C, Zafiriou E, Patsatsi A, Stamatis C, Ntoumou E, Fassos I, Tsalta A, Karra A, Roussaki-Schulze A, Sotiriadis D, Mamuris Z, Sarafidou T. A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population. Pharmacogenomics J. 2014 Jun 3. PMID: 24889923.
  38. Beuselinck B, Lambrechts D, Van Brussel T, Wolter P, Cardinaels N, Joniau S, Lerut E, Karadimou A, Couchy G, Sebe P, Ravaud A, Zerbib M, Caty A, Paridaens R, Schöffski P, Verkarre V, Berger J, Patard JJ, Zucman-Rossi J, Oudard S. Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib. Acta Oncol. 2014 May 301-10. PMID: 24874929.
  39. Rustemoglu A, Gumus-Akay G, Karakus N, Yigit S, Sahin S, Tasliyurt T. Association analysis of three ABCB1 (MDR1) gene variants (C1236T, G2677A/T and C3435T) and their genotype/haplotype combinations with the familial Mediterranean fever. Xenobiotica. 2014 Apr 28. PMID: 24773260.
  40. Tulsyan S, Chaturvedi P, Singh AK, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B. Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach. Gene. 2014 Apr 2. PMID: 24704000.
  41. Nahar R, Saxena R, Deb R, Parakh R, Shad S, Sethi PK, Takkar P, Verma IC. CYP2C9, VKORC1, CYP4F2, ABCB1 and F5 variants: Influence on quality of long-term anticoagulation. Pharmacol Rep. 2014 Apr;66(2):243-9. PMID: 24911077.
  42. Zu B, Li Y, Wang X, He D, Huang Z, Feng W. MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis. Pharmacogenomics. 2014 Apr;15(5):667-77. PMID: 24798723.
  43. Vivona D, Lima LT, Rodrigues AC, Bueno CT, Alcantara GK, Barros LS, DE Moraes Hungria VT, Chiattone CS, DE Lourdes Lopes Ferrari Chauffaille M, Guerra-Shinohara EM. ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib. Oncol Lett. 2014 Apr;7(4):1313-1319. PMID: 24660038.
  44. Schoeppler KE, Aquilante CL, Kiser TH, Fish DN, Zamora MR. The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients. Clin Transplant. 2014 Mar 13. PMID: 24628014.
  45. Ferrari M, Guasti L, Maresca A, Mirabile M, Contini S, Grandi AM, Marino F, Cosentino M. Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2. Eur J Clin Pharmacol. 2014 Mar 6. PMID: 24595600.
  46. Cusinato DA, Lacchini R, Romao EA, Moysés-Neto M, Coelho EB. Relationship of Cyp3a5 Genotype and Abcb1 Diplotype to Tacrolimus Disposition in Brazilian Kidney Transplant Patients. Br J Clin Pharmacol. 2014 Feb 17. PMID: 24528196.
  47. Xuan M, Li H, Fu R, Yang Y, Zhang D, Zhang X, Yang R. Association of ABCB1 gene polymorphisms and haplotypes with therapeutic efficacy of glucocorticoids in Chinese patients with immune thrombocytopenia. Hum Immunol. 2014 Jan 29. PMID: 24486577.
  48. Alzoubi KH, Khabour OF, Al-Azzam SI, Mayyas F, Mhaidat NM. The role of Multidrug Resistance-1 (MDR1) variants in response to atorvastatin among Jordanians. Cytotechnology. 2014 Jan 11. PMID: 24414406.
  49. Baskin Y, Amirfallah A, Calibasi G, Olgun N. Hepatopathy-Thrombocytopenia Syndrome During Actinomycin D Treatment May Be Related to MDR1 (ABCB1) Gene Polymorphisms. Am J Ther. 2014 Jan 9. PMID: 24413370.
  50. Xue Y, Zhao ZQ, Hong D, Zhang HJ, Chen HX, Fan SW. MDR1 Gene Polymorphisms Are Associated with Glucocorticoid-Induced Avascular Necrosis of the Femoral Head in a Chinese Population. Genet Test Mol Biomarkers. 2014 Jan 4. PMID: 24387690.
  51. Naumovska Z, Nestorovska AK, Sterjev Z, Filipce A, Dimovski A, Suturkova Lj. Genotype variability and haplotype profile of ABCB1 (MDR1) gene polymorphisms in macedonian population. Prilozi. 2014;35(3):121-34. PMID: 25725700.
  52. Hamzah S, Teh LK, Siew JS, Ahmad G, Wong HS, Zakaria ZA, Salleh MZ. Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients. Can J Physiol Pharmacol. 2014 Jan;92(1):50-7. PMID: 24383873.
  53. Pramanik S, Surendran ST, Devi S, Krishnamurthi K, Chakrabarti T. Frequency and genotype distribution of ABCB1 gene polymorphisms among Maharashtrian population of Central India. Xenobiotica. 2013 Dec 6. PMID: 24308438.
  54. Lee J, Huang H, Chen Y, Lu X. ABCB1 haplotype influences the sirolimus dose requirements in Chinese renal transplant recipients. Biopharm Drug Dispos. 2013 Nov 27. PMID: 24285256.
  55. Kim KA, Joo HJ, Lee HM, Park JY. Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers. Pharmacogenet Genomics. 2013 Nov 14. PMID: 24240480.
  56. Santos M, Carvalho S, Lima L, Nogueira A, Assis J, Mota-Pereira J, Pimentel P, Maia D, Correia D, Gomes S, Cruz A, Medeiros R. Common Genetic Polymorphisms in the ABCB1 Gene Are Associated with Risk of Major Depressive Disorder in Male Portuguese Individuals. Genet Test Mol Biomarkers. 2013 Nov 7. PMID: 24200053.
  57. Ferraresso M, Belingheri M, Turolo S, Ghio L, Tirelli AS, Grillo P, Lepore M, Edefonti A. Long-term effects of ABCB1 and SXR SNPs on the systemic exposure to cyclosporine in pediatric kidney transplant patients. Pharmacogenomics. 2013 Oct;14(13):1605-1613. PMID: 24088131.
  58. Alzoubi KH, Khabour OF, Al-Azzam SI, Mayyas F. The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among Jordanians. Int J Clin Pharmacol Ther. 2013 Sep 17. PMID: 24040855.
  59. Brambila-Tapia AJ. MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. Rev Invest Clin. 2013 Sep-Oct;65(5):445-54. PMID: 24687344.
  60. Youssef DM, Attia TA, El-Shal AS, Abduelometty FA. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: Impact on susceptibility and response to steroids. Gene. 2013 Aug 27. PMID: 23994685.
  61. Skoglund K, Moreno SB, Baytar M, Jönsson JI, Gréen H. ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro. Pharmgenomics Pers Med. 2013 Aug 20;663-72. PMID: 24019750.
  62. Kassogue Y, Dehbi H, Nassereddine S, Quachouh M, Nadifi S. Genotype Variability and Haplotype Frequency of MDR1 (ABCB1) Gene Polymorphism in Morocco. DNA Cell Biol. 2013 Aug 9. PMID: 23930592.
  63. Johnatty SE, Beesley J, Gao B, Chen X, Lu Y, Law MH, Henderson MJ, Russell AJ, Hedditch EL, Emmanuel C, Fereday S, Webb PM, Australian Ovarian Cancer Study Group, Goode EL, Vierkant RA, Fridley BL, Cunningham JM, Fasching PA, Beckmann MW, Ekici AB, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Brown R, Paul J, Lambrechts S, Despierre E, Vergote I, Lester J, Karlan BY, Heitz F, du Bois A, Harter P, Schwaab I, Bean Y, Pejovic T, Levine DA, Goodman MT, Camey ME, Thompson PJ, Lurie G, Shildkraut J, Berchuck A, Terry KL, Cramer DW, Norris MD, Haber M, Macgregor S, Defazio A, Chenevix-Trench G. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol. 2013 Jul 31. PMID: 23917080.
  64. Gómez-Bravo MA, Salcedo M, Fondevila C, Suarez F, Castellote J, Rufian S, Pons JA, Alamo JM, Millán O, Brunet M. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. J Clin Pharmacol. 2013 Jul 30. PMID: 23900887.
  65. Cousar JL, Conley YP, Willyerd FA, Sarnaik AA, Puccio AM, Empey PE, Kochanek PM, Bell MJ, Okonkwo DO, Clark RS. Influence of ATP-Binding Cassette Polymorphisms on Neurological Outcome After Traumatic Brain Injury. Neurocrit Care. 2013 Jul 30. PMID: 23896815.
  66. Boiso Moreno S, Zackrisson AL, Jakobsen Falk I, Karlsson L, Carlsson B, Tillmar A, Kugelberg FC, Ahlner J, Hägg S, Gréen H. ABCB1 gene polymorphisms are associated with suicide in forensic autopsies. Pharmacogenet Genomics. 2013 Jun 29. PMID: 23820292.
  67. Doxani C, Voulgarelis M, Zintzaras E. MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis. Biomarkers. 2013 Jun 27. PMID: 23805980.
  68. Noordam R, Aarts N, Hofman A, van Schaik RH, Stricker BH, Visser LE. Association Between Genetic Variation in the ABCB1 Gene and Switching, Discontinuation, and Dosage of Antidepressant Therapy: Results From the Rotterdam Study. J Clin Psychopharmacol. 2013 Jun 13. PMID: 23771194.
  69. Wu H, Kang H, Liu Y, Xiao Q, Zhang Y, Sun M, Liu D, Wang Z, Zhao H, Yao W, Jia T, Wang E, Zheng Z, Wei M. Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis. Pharmacogenomics. 2013 Jun;14(8):897-911. PMID: 23746184.
  70. Dickens D, Owen A, Alfirevic A, Pirmohamed M. ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein. Pharmacogenet Genomics. 2013 Jun;23(6):314-23. PMID: 23619510.
  71. Chaturvedi P, Tulsyan S, Agarwal G, Lal P, Agarwal S, Mittal RD, Mittal B. Influence of ABCB1 genetic variants in breast cancer treatment outcomes. Cancer Epidemiol. 2013 May 22. PMID: 23707158.
  72. Wang LH, Song YB, Zheng WL, Jiang L, Ma WL. The association between polymorphisms in the MDR1 gene and risk of cancer: a systematic review and pooled analysis of 52 case--control studies. Cancer Cell Int. 2013 May 20;13(1):46. PMID: 23687985.
  73. Choong E, Polari A, Kamdem RH, Gervasoni N, Spisla C, Sirot EJ, Bickel GG, Bondolfi G, Conus P, Eap CB. Pharmacogenetic Study on Risperidone Long-Acting Injection: Influence of Cytochrome P450 2D6 and Pregnane X Receptor on Risperidone Exposure and Drug-Induced Side-Effects. J Clin Psychopharmacol. 2013 Apr 19. PMID: 23609392.
  74. Quaglia M, Terrazzino S, Boldorini R, Stratta P, Genazzani AA. Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms. J Clin Pharm Ther. 2013 Apr 9. PMID: 23574377.
  75. Cortejoso L, García MI, García-Alfonso P, González-Haba E, Escolar F, Sanjurjo M, López-Fernández LA. Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer. Cancer Chemother Pharmacol. 2013 Mar 31. PMID: 23543295.
  76. Fukudo M, Ikemi Y, Togashi Y, Masago K, Kim YH, Mio T, Terada T, Teramukai S, Mishima M, Inui KI, Katsura T. Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer. Clin Pharmacokinet. 2013 Mar 27. PMID: 23532985.
  77. Bellusci CP, Rocco C, Aulicino P, Mecikovsky D, Curras V, Hegoburu S, Bramuglia GF, Bologna R, Sen L, Mangano A. Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children. Gene. 2013 Mar 22. PMID: 23528223.
  78. Karlsson L, Green H, Zackrisson AL, Bengtsson F, Jakobsen Falk I, Carlsson B, Ahlner J, Kugelberg FC. ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram. Int J Legal Med. 2013 Mar 21. PMID: 23515680.
  79. Zhang Y, Li JL, Fu Q, Wang XD, Liu LS, Wang CX, Xie W, Chen ZJ, Shu WY, Huang M. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients. Acta Pharmacol Sin. 2013 Mar 18. PMID: 23503472.
  80. Khabour OF, Alzoubi KH, Al-Azzam SI, Mhaidat NM. Frequency of MDR1 single nucleotide polymorphisms in a Jordanian population, including a novel variant. Genet Mol Res. 2013 Mar 13;12(1):801-8. PMID: 23546964.
  81. Beuselinck B, Karadimou A, Lambrechts D, Claes B, Wolter P, Couchy G, Berkers J, Paridaens R, Schöffski P, Méjean A, Verkarre V, Lerut E, de la Taille A, Tourani JM, Bigot P, Linassier C, Négrier S, Berger J, Patard JJ, Zucman-Rossi J, Oudard S. Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib. Br J Cancer. 2013 Mar 5;108(4):887-900. PMID: 23462807.
  82. Zhou Q, Chen QX, Ruan ZR, Yuan H, Xu HM, Zeng S. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics. Pharmazie. 2013 Mar;68(3):187-94. PMID: 23556337.
  83. Omoumi A, Wang Z, Yeow V, Wu-Chou YH, Chen PK, Ruczinski I, Cheng J, Cheah FS, Lee CG, Beaty TH, Chong SS. Fetal polymorphisms at the ABCB1-transporter gene locus are associated with susceptibility to non-syndromic oral cleft malformations. Eur J Hum Genet. 2013 Feb 27. PMID: 23443032.
  84. Zhou Q, Ruan ZR, Yuan H, Xu DH, Zeng S. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics. Pharmazie. 2013 Feb;68(2):129-34. PMID: 23469685.
  85. Yoon SH, Cho JH, Kwon O, Choi JY, Park SH, Kim YL, Yoon YR, Won DI, Kim CD. CYP3A and ABCB1 Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Tacrolimus and Its Metabolites (M-I and M-III). Transplantation. 2013 Jan 29. PMID: 23364483.
  86. Dogruer D, Tug E, Bes C, Soy M. Lack of an effect of CYP3A4 and MDR1 gene polymorphisms on colchicine pharmacogenetics in the treatment of Familial Mediterranean fever. Genet Mol Res. 2013 Jan 24;12(AOP). PMID: 23408444.
  87. Yang J, Wang ZG, Cai HQ, Li YC, Xu YL. Effect of Variation of ABCB1 and ABCC3 Genotypes on the Survival of Bone Tumor Cases after Chemotherapy. Asian Pac J Cancer Prev. 2013;14(8):4595-4598. PMID: 24083708.
  88. Fountzilas G, Kotoula V, Pectasides D, Kouvatseas G, Timotheadou E, Bobos M, Mavropoulou X, Papadimitriou C, Vrettou E, Raptou G, Koutras A, Razis E, Bafaloukos D, Samantas E, Pentheroudakis G, Skarlos DV. Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial. PLoS One. 2013;8(7):e69256. PMID: 23935969.
  89. Llaudó I, Colom H, Giménez-Bonafé P, Torras J, Caldés A, Sarrias M, Cruzado JM, Oppenheimer F, Sánchez-Plumed J, Gentil MA, Ekberg H, Grinyó JM, Lloberas N. Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study. Transpl Int. 2012 Dec 7. PMID: 23216707.
  90. . [Pharmacogenetic criteria drug-resistence epilepsy]. Lik Sprava. 2012 Dec(8):71-4. PMID: 23786015.
  91. Kim YO, Kim SY, Yun DH, Lee SW. Association between ABCB1 Polymorphisms and Ischemic Stroke in Korean Population. Exp Neurobiol. 2012 Dec;21(4):164-71. PMID: 23319877.
  92. Wang YY, Zhang M, Lu FM, Jiao Z, Qiu XY. CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients. Chin Med J (Engl). 2012 Dec;125(23):4233-8. PMID: 23217392.
  93. Ozhan G, Kara M, Sari FM, Yanar HT, Ercan G, Alpertunga B. Associations Between The Functional Polymorphisms in The ABCB1 Transporter Gene and Colorectal Cancer Risk: A Case-Control Study in Turkish Population. Toxicol Mech Methods. 2012 Nov 29. PMID: 23193993.
  94. Singh AB, Bousman CA, Ng CH, Byron K, Berk M. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression. Transl Psychiatry. 2012 Nov 27;2e198. PMID: 23188198.
  95. Chan SW, Hu M, Ko SS, Tam CW, Fok BS, Yin OQ, Chow MS, Tomlinson B. CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects. Eur J Clin Pharmacol. 2012 Oct 23. PMID: 23090703.
  96. Hu LL, Yu B, Yang J. MDR1 polymorphisms associated with risk of and survival in diffuse large B-cell lymphoma. Leuk Lymphoma. 2012 Oct 22. PMID: 23088763.
  97. Assema DM, Lubberink M, Rizzu P, Swieten JC, Schuit RC, Eriksson J, Scheltens P, Koepp M, Lammertsma AA, Berckel BN. Blood--brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene. EJNMMI Res. 2012 Oct 16;2(1):57. PMID: 23067778.
  98. Sam WJ, Chamberlain CE, Lee SJ, Goldstein JA, Hale DA, Mannon RB, Kirk AD, Hon YY. Associations of ABCB1 and IL-10 Genetic Polymorphisms With Sirolimus-Induced Dyslipidemia in Renal Transplant Recipients. Transplantation. 2012 Oct 15. PMID: 23073467.
  99. Al-Mohizea AM, Alkharfy KM, Bagulb KM, Alghamdi AM, Al-Jenoobi FI, Al-Muhsen S, Halwani R, Khalid Parvez M, Al-Dosari MS. Genetic variability and haplotype profile of MDR1 in Saudi Arabian males. Mol Biol Rep. 2012 Oct 7. PMID: 23053935.
  100. Lovrić M, Božina N, Hajnšek S, Kuzman MR, Sporiš D, Lalić Z, Božina T, Granić P. Association Between Lamotrigine Concentrations and ABCB1 Polymorphisms in Patients With Epilepsy. Ther Drug Monit. 2012 Oct;34(5):518-25. PMID: 22972536.
  101. Zhai X, Wang H, Zhu X, Miao H, Qian X, Li J, Gao Y, Lu F, Wu Y. Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia. Arch Med Sci. 2012 Sep 8;8(4):659-71. PMID: 23056078.
  102. Lü H, DU ZZ, Wang W, Wang W, Zhao WL, Wang Y, Hu SY, Chai YH. [Relationship between genetic polymorphism of multidrug resistance 1 gene and the risk of childhood acute lymphocytic leukemia]. Zhonghua Er Ke Za Zhi. 2012 Sep;50(9):692-6. PMID: 23158821.
  103. Song J, Kim MG, Choi B, Han NY, Yun HY, Yoon JH, Oh JM. CYP3A5 Polymorphism Effect on Cyclosporine Pharmacokinetics in Living Donor Renal Transplant Recipients: Analysis by Population Pharmacokinetics. Ann Pharmacother. 2012 Sep;46(9):1141-51. PMID: 22947591.
  104. Zhou Q, Ruan ZR, Yuan H, Zeng S. CYP2C9*3(1075A>C), MDR1 G2677T/A and MDR1 C3435T are Determinants of Inter-subject Variability in Fluvastatin Pharmacokinetics in Healthy Chinese Volunteers. Arzneimittelforschung. 2012 Aug 31. PMID: 22941809.
  105. Kim JW, Kim JH, Im SA, Kim YJ, Han HS, Kim JS, Han SW, Jeon YK, Oh DY, Han W, Kim TY, Park IA, Noh DY, Bang YJ. ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy. Oncology. 2012 Aug 16;83(4):218-227. PMID: 22906996.
  106. García M, Macías RM, Cubero JJ, Benítez J, Caravaca F, Gervasini G. ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients. Eur J Clin Pharmacol. 2012 Aug 11. PMID: 22886152.
  107. Vaclavikova R, Ehrlichova M, Hlavata I, Pecha V, Kozevnikovova R, Trnkova M, Adamek J, Edvardsen H, Kristensen VN, Gut I, Soucek P. Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis. Clin Chem Lab Med. 2012 Jun 23. PMID: 23093106.
  108. Rustemoglu A, Gül U, Gümüş-Akay G, Gönül M, Yiğit S, Bozkurt N, Karadağ A, Pişkin E, Sunguroğlu A, Kadıkıran A. MDR1 Gene Polymorphisms May Be Associated with Behçet's Disease and Its Colchicum Treatment Response. Gene. 2012 Jun 14. PMID: 22705826.
  109. Mizuno T, Fukudo M, Terada T, Kamba T, Nakamura E, Ogawa O, Inui KI, Katsura T. Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. Drug Metab Pharmacokinet. 2012 Jun 5. PMID: 22673043.
  110. Chiou YH, Wang LY, Wang TH, Huang SP. Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2012 May 20. PMID: 22610055.
  111. Wu H, Kang H, Liu Y, Tong W, Liu D, Yang X, Lian M, Yao W, Zhao H, Huang D, Sha X, Wang E, Wei M. Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes. J Cancer Res Clin Oncol. 2012 Apr 19. PMID: 22526155.
  112. Qiu H, Dong H, Pan S, Miao K. The single nucleotide polymorphism and haplotype analysis of MDR1 in Jiangsu Han population of China. Biomed Pharmacother. 2012 Apr 3. PMID: 22902647.
  113. Xiang Q, Cui YM, Zhao X, Yan L, Zhou Y. The Influence of MDR1 G2677T/A Genetic Polymorphisms on the Pharmacokinetics of Repaglinide in Healthy Chinese Volunteers. Pharmacology. 2012 Mar 6;89(1-2):105-110. PMID: 22398664.
  114. Scheiner MA, da Cunha Vasconcelos F, da Matta RR, Dal Bello Figueira R Jr, Maia RC. ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients. J Cancer Res Clin Oncol. 2012 Feb 23. PMID: 22358301.
  115. Fujii T, Ota M, Hori H, Sasayama D, Hattori K, Teraishi T, Yamamoto N, Hashikura M, Tatsumi M, Higuchi T, Kunugi H. Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population. J Psychiatr Res. 2012 Feb 3. PMID: 22306099.
  116. Bly MJ, Bishop JR, Thomas KL, Ellingrod VL. P-glycoprotein (PGP) Polymorphisms and Sexual Dysfunction in Female Patients With Depression and SSRI-Associated Sexual Side Effects. J Sex Marital Ther. 2012 Jan 31. PMID: 23356581.
  117. Hu M, Yang YL, Fok BS, Chan SW, Chu TT, Poon EW, Yin OQ, Lee VH, Tomlinson B. Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects. Drug Metabol Drug Interact. 2012 Jan 9;27(1):33-9. PMID: 22718623.
  118. . [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing]. Eksp Klin Farmakol. 2012;75(10):29-36. PMID: 23240156.
  119. Barratt DT, Coller JK, Hallinan R, Byrne A, White JM, Foster DJ, Somogyi AA. ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics. Pharmgenomics Pers Med. 2012;553-62. PMID: 23226062.
  120. Swart M, Ren Y, Smith P, Dandara C. ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients. Front Genet. 2012;3236. PMID: 23133441.
  121. Cho JH, Yoon YD, Park JY, Song EJ, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD. Impact of Cytochrome P450 3A and ATP-Binding Cassette Subfamily B Member 1 Polymorphisms on Tacrolimus Dose-Adjusted Trough Concentrations Among Korean Renal Transplant Recipients. Transplant Proc. 2012 Jan;44(1):109-14. PMID: 22310591.
  122. Rüstemoglu A, Gumus-Akay G, Yigit S, Tasliyurt T. Analysis of common MDR1 (ABCB1) gene C1236T and C3435T polymorphisms in Turkish patients with familial Mediterranean fever. Genet Mol Res. 2011 Dec 14;10(4). PMID: 22194207.
  123. Kesimci E, Engin AB, Kanbak O, Karahalil B. Association between ABCB1 gene polymorphisms and fentanyl's adverse effects in Turkish patients undergoing spinal anesthesia. Gene. 2011 Dec 13. PMID: 22197686.
  124. Sortica VD, Ojopi EB, Genro JP, Callegari-Jacques S, Ribeiro-Dos-Santos A, de Moraes MO, Romano-Silva MA, Pena SD, Suarez-Kurtz G, Hutz MH. Influence of Genomic Ancestry on the Distribution of SLCO1B1, SLCO1B3 and ABCB1 Gene Polymorphisms among Brazilians. Basic Clin Pharmacol Toxicol. 2011 Dec 3. PMID: 22136368.
  125. Vivona D, Bueno CT, Lima LT, Hirata RD, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells Mol Dis. 2011 Nov 29. PMID: 22134106.
  126. Stratta P, Quaglia M, Cena T, Antoniotti R, Fenoglio R, Menegotto A, Ferrante D, Genazzani A, Terrazzino S, Magnani C. The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation. Eur J Clin Pharmacol. 2011 Nov 20. PMID: 22101623.
  127. Sam WJ, Chamberlain CE, Lee SJ, Goldstein JA, Hale DA, Mannon RB, Kirk AD, Yi Hon Y. Associations of ABCB1 3435C>T and IL-10 -1082G>A Polymorphisms With Long-Term Sirolimus Dose Requirements in Renal Transplant Patients. Transplantation. 2011 Nov 16. PMID: 22094953.
  128. Dong L, Mao M, Luo R, Tong Y, Yu D. Common ABCB1 polymorphisms associated with susceptibility to infantile spasms in the Chinese Han population. Genet Mol Res. 2011 Oct 19;10(4):2569-77. PMID: 22033938.
  129. Garcia-Donas J, Esteban E, Leandro-García LJ, Castellano DE, Del Alba AG, Climent MA, Arranz JA, Gallardo E, Puente J, Bellmunt J, Mellado B, Martínez E, Moreno F, Font A, Robledo M, Rodríguez-Antona C. Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study. Lancet Oncol. 2011 Oct 17. PMID: 22015057.
  130. Shi XJ, Geng F, Jiao Z, Cui XY, Qiu XY, Zhong MK. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis. J Clin Pharm Ther. 2011 Oct;36(5):614-24. PMID: 21916909.
  131. Bergmann TK, Andersen CB, Gréen H, Mirza MR, Skougaard K, Wihl J, Keldsen N, Damkier P, Peterson C, Vach W, Brøsen K. Impact of ABCB1 Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer. Basic Clin Pharmacol Toxicol. 2011 Sep 28. PMID: 21955855.
  132. Koh Y, Kim I, Shin DY, Bae JY, Kim HK, Yoon SS, Park SS, Lee DS, Park S, Kim BK. Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011 Sep 3. PMID: 21896346.
  133. Zintzaras E. Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease? Inflamm Bowel Dis. 2011 Sep 1. PMID: 21887726.
  134. Perwitasari DA, Wessels JA, van der Straaten RJ, Baak-Pablo RF, Mustofa M, Hakimi M, Nortier JW, Gelderblom H, Guchelaar HJ. Association of ABCB1, 5-HT3B Receptor and CYP2D6 Genetic Polymorphisms with Ondansetron and Metoclopramide Antiemetic Response in Indonesian Cancer Patients Treated with Highly Emetogenic Chemotherapy. Jpn J Clin Oncol. 2011 Aug 11. PMID: 21840870.
  135. Santoro A, Felipe CR, Tedesco-Silva H, Medina-Pestana JO, Struchiner CJ, Ojopi EB, Suarez-Kurtz G. Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. Pharmacogenomics. 2011 Aug 1. PMID: 21806386.
  136. Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Addict Biol. 2011 Jul 25. PMID: 21790905.
  137. Jordán de Luna C, Herrero Cervera MJ, Sánchez Lázaro I, Almenar Bonet L, Poveda Andrés JL, Aliño Pellicer SF. Pharmacogenetic Study of ABCB1 and CYP3A5 Genes During the First Year Following Heart Transplantation Regarding Tacrolimus or Cyclosporine Levels. Transplant Proc. 2011 Jul-Aug;43(6):2241-3. PMID: 21839244.
  138. Drain S, Flannely L, Drake MB, Kettle P, Orr N, Bjourson AJ, Catherwood MA, Alexander HD. Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. Leuk Res. 2011 Jun 24. PMID: 21705081.
  139. Choi HJ, Cho HY, Ro H, Lee SH, Han KH, Lee H, Kang HG, Ha IS, Choi Y, Cheong HI. Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Pediatr Nephrol. 2011 May 8. PMID: 21553324.
  140. Qiu F, He XJ, Sun YX, Li-Ling J, Zhao LM. Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients. Pharmacol Rep. 2011 May-Jun;63(3):815-25. PMID: 21857093.
  141. Milojkovic M, Stojnev S, Jovanovic I, Ljubisavljevic S, Stefanovic V, Sunder-Plassman R. Frequency of the C1236T, G2677T/A and C3435T MDR1 gene polymorphisms in the Serbian population. Pharmacol Rep. 2011 May-Jun;63(3):808-14. PMID: 21857092.
  142. Das A, Balan S, Mathew A, Radhakrishnan V, Banerjee M, Radhakrishnan K. Corpora amylacea deposition in the hippocampus of patients with mesial temporal lobe epilepsy: A new role for an old gene? Indian J Hum Genet. 2011 May;17 Suppl 1S41-7. PMID: 21747587.
  143. Kumari R, Lakhan R, Garg RK, Kalita J, Misra UK, Mittal B. Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population. Indian J Hum Genet. 2011 May;17 Suppl 1S32-40. PMID: 21747585.
  144. Haerian BS, Lim KS, Mohamed EH, Tan HJ, Tan CT, Raymond AA, Wong CP, Wong SW, Mohamed Z. Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy. Seizure. 2011 Apr 27. PMID: 21530324.
  145. Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y. Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Behav. 2011 Apr 12. PMID: 21493161.
  146. Dong HJ, Miao KR, Qiao C, Zhuang Y, Shen WY, Hong M, Fan L, Liu P, Xu W, Li JY. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population. Leuk Lymphoma. 2011 Apr 4. PMID: 21463115.
  147. . [Genetic performance criteria valproate in patients with epilepsy]. Lik Sprava. 2011 Apr-Jun(3-4):113-9. PMID: 22416375.
  148. Taegtmeyer AB, Breen JB, Smith J, Rogers P, Kullak-Ublick GA, Yacoub MH, Banner NR, Barton PJ. Effect of ABCB1 Genotype on Pre- and Post-Cardiac Transplantation Plasma Lipid Concentrations. J Cardiovasc Transl Res. 2011 Mar 29. PMID: 21445698.
  149. Dong L, Luo R, Tong Y, Cai X, Mao M, Yu D. Lack of association between ABCB1 gene polymorphisms and pharmacoresistant epilepsy: an analysis in a western Chinese pediatric population. Brain Res. 2011 Mar 18. PMID: 21420937.
  150. Haerian BS, Lim KS, Tan HJ, Mohamed EH, Tan CT, Raymond AA, Wong CP, Wong SW, Omar H, Roslan H, Mohamed Z. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. Epileptic Disord. 2011 Mar 17. PMID: 21388909.
  151. Haerian BS, Lim KS, Tan CT, Raymond AA, Mohamed Z. Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis. Pharmacogenomics. 2011 Mar 11. PMID: 21391884.
  152. Neuvonen AM, Palo JU, Sajantila A. Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users. Int J Legal Med. 2011 Mar;125(2):265-9. PMID: 21311904.
  153. Herrlinger KR, Koc H, Winter S, Teml A, Stange EF, Fellermann K, Fritz P, Schwab M, Schaeffeler E. ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis. Clin Pharmacol Ther. 2011 Mar;89(3):422-8. PMID: 21289623.
  154. Zhang X, Wang Z, Fan J, Liu G, Peng Z. Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period. Eur J Clin Pharmacol. 2011 Feb 26. PMID: 21359536.
  155. Bergmann TK, Gréen H, Brasch-Andersen C, Mirza MR, Herrstedt J, Hølund B, du Bois A, Damkier P, Vach W, Brosen K, Peterson C. Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer. Eur J Clin Pharmacol. 2011 Feb 16. PMID: 21327421.
  156. Haerian BS, Lim KS, Mohamed EH, Tan HJ, Tan CT, Raymond AA, Wong CP, Wong SW, Mohamed Z. Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. Seizure. 2011 Feb 10. PMID: 21316268.
  157. Li L, Li CJ, Zhang YJ, Zheng L, Jiang HX, Si-Tu B. Simultaneous detection of CYP3A5 and MDR1 polymorphisms based on the SNaPshot assay. Clin Biochem. 2011 Jan 12. PMID: 21237140.
  158. Yu X, Xie H, Wei B, Zhang M, Wang W, Wu J, Yan S, Zheng S, Zhou L. Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients. PLoS One. 2011;6(11):e25933. PMID: 22110582.
  159. Caronia D, Patiño-Garcia A, Peréz-Martínez A, Pita G, Moreno LT, Zalacain-Díez M, Molina B, Colmenero I, Sierrasesúmaga L, Benítez J, Gonzalez-Neira A. Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study. PLoS One. 2011;6(10):e26091. PMID: 22016816.
  160. Cascorbi I. P-glycoprotein: Tissue Distribution, Substrates, and Functional Consequences of Genetic Variations. Handb Exp Pharmacol. 2011;201261-83. PMID: 21103972.
  161. Sipeky C, Csongei V, Jaromi L, Safrany E, Maasz A, Takacs I, Beres J, Fodor L, Szabo M, Melegh B. Genetic variability and haplotype profile of MDR1 (ABCB1) gene in Roma and Hungarian population samples with a review of the literature. Drug Metab Pharmacokinet. 2010 Dec 17. PMID: 21178299.
  162. Nikisch G, Baumann P, Oneda B, Kiessling B, Weisser H, Mathé AA, Yoshitake T, Kehr J, Wiedemann G, Eap CB. Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study. J Psychopharmacol. 2010 Dec 8. PMID: 21148022.
  163. Gonzalez-Haba E, García MI, Cortejoso L, López-Lillo C, Barrueco N, García-Alfonso P, Alvarez S, Jiménez JL, Martín ML, Muñóz-Fernández MA, Sanjurjo M, López-Fernández LA. ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients. Pharmacogenomics. 2010 Dec;11(12):1715-23. PMID: 21142915.
  164. Onizuka M, Kunii N, Toyosaki M, Machida S, Ohgiya D, Ogawa Y, Kawada H, Inoko H, Ando K. Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients. Bone Marrow Transplant. 2010 Nov 22. PMID: 21102498.
  165. van der Veldt AA, Eechoute K, Gelderblom H, Gietema JA, Guchelaar HJ, van Erp N, Van den Eertwegh AJ, Haanen JB, Mathijssen RH, Wessels JA. Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib. Clin Cancer Res. 2010 Nov 19. PMID: 21097692.
  166. Turolo S, Tirelli AS, Ferraresso M, Ghio L, Belingheri M, Groppali E, Torresani E, Edefonti A. Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation. Pharmacol Rep. 2010 November-December;62(6):1159-1169. PMID: 21273673.
  167. Gréen H, Falk IJ, Lotfi K, Paul E, Hermansson M, Rosenquist R, Paul C, Nahi H. Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. Pharmacogenomics J. 2010 Oct 12. PMID: 20938465.
  168. Magliulo L, Dahl ML, Lombardi G, Fallarini S, Villa LM, Biolcati A, Scordo MG. Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment? Eur J Clin Pharmacol. 2010 Oct 8. PMID: 20931330.
  169. Akamine Y, Miura M, Sunagawa S, Kagaya H, Yasui-Furukori N, Uno T. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers. Xenobiotica. 2010 Sep 14. PMID: 20839930.
  170. Harmsze AM, van Werkum JW, Ten Berg JM, Zwart B, Bouman HJ, Breet NJ, van 't Hof AW, Ruven HJ, Hackeng CM, Klungel OH, de Boer A, Deneer VH. CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. Eur Heart J. 2010 Sep 10. PMID: 20833683.
  171. Ichikawa M, Miwa K, Yamasaki T, Nakagawa I, Takizawa S, Masuda S, Inui KI. Time-saving mutiplex detection of Single Nucleotide Polymorphisms by ultrasensitive DNA microarray. J Biochem. 2010 Aug 19. PMID: 20716514.
  172. Fajac A, Gligorov J, Rezai K, Lévy P, Lévy E, Selle F, Beerblock K, Avenin D, Saintigny P, Hugonin S, Bernaudin JF, Lokiec F. Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients. Br J Cancer. 2010 Jul 13. PMID: 20628376.
  173. Singh R, Srivastava A, Kapoor R, Mittal RD. Do Drug Transporter (ABCB1) SNPs Influence Cyclosporine and Tacrolimus Dose Requirements and Renal Allograft Outcome in the Posttransplantation Period? J Clin Pharmacol. 2010 Jun 22. PMID: 20571034.
  174. Balcerczak E, Panczyk M, Piaskowski S, Pasz-Walczak G, Sa?agacka A, Mirowski M. ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer. Int J Colorectal Dis. 2010 Jun 9. PMID: 20533057.
  175. Sia AT, Sng BL, Lim EC, Law H, Tan EC. The influence of ATP-binding cassette sub-family B member -1 (ABCB1) genetic polymorphisms on acute and chronic pain after intrathecal morphine for caesarean section: a prospective cohort study. Int J Obstet Anesth. 2010 Jun 1. PMID: 20627697.
  176. Cho HY, Yoo HD, Lee YB. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects. Neuroscience. 2010 Apr 30. PMID: 20438811.
  177. Grover S, Bala K, Sharma S, Gourie-Devi M, Baghel R, Kaur H, Gupta M, Talwar P, Kukreti R. Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients. Biochimie. 2010 Apr 24. PMID: 20417680.
  178. Bergmann TK, Brasch-Andersen C, Gréen H, Mirza M, Pedersen RS, Nielsen F, Skougaard K, Wihl J, Keldsen N, Damkier P, Friberg LE, Peterson C, Vach W, Karlsson MO, Brosen K. Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. Pharmacogenomics J. 2010 Apr 6. PMID: 20368717.
  179. Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II. Clin Pharmacokinet. 2010 Apr 1;49(4):207-21. PMID: 20214406.
  180. Xiang Q, Zhao X, Zhou Y, Duan JL, Cui YM. Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety. J Clin Pharmacol. 2010 Mar 23. PMID: 20332423.
  181. Staatz CE, Goodman LK, Tett SE. Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I. Clin Pharmacokinet. 2010 Mar 1;49(3):141-75. PMID: 20170205.
  182. Bray J, Sludden J, Griffin MJ, Cole M, Verrill M, Jamieson D, Boddy AV. Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide. Br J Cancer. 2010 Feb 23. PMID: 20179710.
  183. Li D, Abudula A, Abulahake M, Zhu AP, Lou YQ, Zhang GL. Influence of CYP3A5 and MDR1 Genetic Polymorphisms on Urinary 6{beta}-Hydroxycortisol/Cortisol Ratio After Grapefruit Juice Intake in Healthy Chinese. J Clin Pharmacol. 2010 Feb 16. PMID: 20160155.
  184. Bellusci CP, Rocco CA, Aulicino PC, Mecikovsky D, Bologna R, Sen L, Mangano A. MDR1 3435T and 1236T alleles delay disease progression to pediatric AIDS but have no effect on HIV-1 vertical transmission. AIDS. 2010 Jan 30. PMID: 20124970.
  185. Yoo HD, Cho HY, Lee YB. Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1. Br J Clin Pharmacol. 2010 Jan;69(1):27-37. PMID: 20078610.
  186. Gümü?-Akay G, Rüstemo?lu A, Karada? A, Sunguro?lu A. Haplotype-Based Analysis of MDR1/ABCB1 Gene Polymorphisms in a Turkish Population. DNA Cell Biol. 2009 Dec 21. PMID: 20025534.
  187. Yanagimachi M, Naruto T, Tanoshima R, Kato H, Yokosuka T, Kajiwara R, Fujii H, Tanaka F, Goto H, Yagihashi T, Kosaki K, Yokota S. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation. Clin Transplant. 2009 Dec 20. PMID: 20030680.
  188. Correia CT, Almeida JP, Santos PE, Sequeira AF, Marques CE, Miguel TS, Abreu RL, Oliveira GG, Vicente AM. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. Pharmacogenomics J. 2009 Dec 8. PMID: 19997080.
  189. Chen B, Zhang W, Fang J, Jin Z, Li J, Yu Z, Cai W. Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients. Xenobiotica. 2009 Dec;39(12):931-938. PMID: 19925383.
  190. Harmsze A, van Werkum JW, Bouman HJ, Ruven HJ, Breet NJ, Ten Berg JM, Hackeng CM, Tjoeng MM, Klungel OH, de Boer A, Deneer VH. Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation. Pharmacogenet Genomics. 2009 Nov 19. PMID: 19934793.
  191. Hemauer SJ, Nanovskaya TN, Abdel-Rahman SZ, Patrikeeva SL, Hankins GD, Ahmed MS. Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochem Pharmacol. 2009 Nov 5. PMID: 19896927.
  192. Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males. Pharmacogenomics. 2009 Nov;10(11):1743-51. PMID: 19891551.
  193. Benish RL, Rodriguez B, Zimmerman PA, Mehlotra RK. Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations. Infect Genet Evol. 2009 Oct 8. PMID: 19819348.
  194. Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Ch Stricker BH. Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy. Pharmacoepidemiol Drug Saf. 2009 Oct 2. PMID: 19802823.
  195. Chen B, Zhang W, Fang J, Jin Z, Li J, Yu Z, Cai W. Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients. Xenobiotica. 2009 Sep 21. PMID: 19769534.
  196. Kim HJ, Hwang SY, Kim JH, Park HJ, Lee SG, Lee SW, Joo JC, Kim YK. Association between Genetic Polymorphism of Multidrug Resistance 1 Gene and Sasang Constitutions. Evid Based Complement Alternat Med. 2009 Sep;6 Suppl 173-80. PMID: 19745014.
  197. Hawwa AF, McKiernan PJ, Shields M, Millership JS, Collier PS, McElnay JC. Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant. Br J Clin Pharmacol. 2009 Sep;68(3):413-21. PMID: 19740399.
  198. Anderson PL, Aquilante CL, Gardner EM, Predhomme J, McDaneld P, Bushman LR, Zheng JH, Ray M, Mawhinney S. Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. J Antimicrob Chemother. 2009 Aug 26. PMID: 19710077.
  199. Huebner C, Browning BL, Petermann I, Yeo Han D, Philpott M, Barclay M, Gearry R, McCulloch A, Demmers P, Ferguson LR. Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. Inflamm Bowel Dis. 2009 Aug 14. PMID: 19685447.
  200. van Erp NP, Eechoute K, van der Veldt AA, Haanen JB, Reyners AK, Mathijssen RH, Boven E, van der Straaten T, Baak-Pablo RF, Wessels JA, Guchelaar HJ, Gelderblom H. Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity. J Clin Oncol. 2009 Aug 10. PMID: 19667267.
  201. Consoli G, Lastella M, Ciapparelli A, Dell'Osso MC, Ciofi L, Guidotti E, Danesi R, Dell'Osso L, Del Tacca M, Di Paolo A. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients. Pharmacogenomics. 2009 Aug;10(8):1267-76. PMID: 19663671.
  202. Scheiner MA, Damasceno AM, Maia RC. ABCB1 single nucleotide polymorphisms in the Brazilian population. Mol Biol Rep. 2009 May 13. PMID: 19437139.
  203. Panczyk M, Balcerczak E, Piaskowski S, Jamroziak K, Pasz-Walczak G, Mirowski M. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer. Int J Colorectal Dis. 2009 May 5. PMID: 19415305.
  204. Yin OQ, Tomlinson B, Chow MS. Effect of multidrug resistance gene-1 (ABCB1) polymorphisms on the single-dose pharmacokinetics of cloxacillin in healthy adult Chinese men. Clin Ther. 2009 May;31(5):999-1006. PMID: 19539100.
  205. Correia C, Santos P, Coutinho AM, Vicente AM. Characterization of pharmacogenetically relevant CYP2D6 and ABCB1 gene polymorphisms in a Portuguese population sample. Cell Biochem Funct. 2009 Apr 29. PMID: 19405050.
  206. Kolesar JM, Hamidovic A, Hahn K. Clinical Significance of ABCB1 Genotyping in Oncology. J Oncol Pharm Pract. 2009 Apr 28. PMID: 19401306.
  207. Nakamura T, Okamura N, Yagi M, Omatsu H, Yamamori M, Kuwahara A, Nishiguchi K, Horinouchi M, Okumura K, Sakaeda T. Effects of ABCB1 3435C>T genotype on serum levels of cortisol and aldosterone in women with normal menstrual cycles. Genet Mol Res. 2009 Apr 7;8(2):397-403. PMID: 19440975.
  208. Mendes J, Martinho A, Simoes O, Mota A, Breitenfeld L, Pais L. Genetic Polymorphisms in CYP3A5 and MDR1 Genes and Their Correlations With Plasma Levels of Tacrolimus and Cyclosporine in Renal Transplant Recipients. Transplant Proc. 2009 Apr;41(3):840-2. PMID: 19376366.
  209. Tsai SM, Lin CY, Wu SH, Hou LA, Ma H, Tsai LY, Hou MF. Side Effects after Docetaxel Treatment in Taiwanese Breast Cancer Patients with CYP3A4, CYP3A5, and ABCB1 Gene Polymorphisms. Clin Chim Acta. 2009 Mar 27. PMID: 19332043.
  210. Parathyras J, Gebhardt S, Hillermann-Rebello R, Grobbelaar N, Venter M, Warnich L. A pharmacogenetic study of CD4 recovery in response to HIV antiretroviral therapy in two South African population groups. J Hum Genet. 2009 Mar 13. PMID: 19282874.
  211. Fung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta. 2009 Mar 10. PMID: 19285158.
  212. Jeannesson E, Siest G, Bastien B, Albertini L, Aslanidis C, Schmitz G, Visvikis-Siest S. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the Stanislas Cohort. Clin Chim Acta. 2009 Mar 10. PMID: 19285054.
  213. Westerlund M, Belin AC, Anvret A, Håkansson A, Nissbrandt H, Lind C, Sydow O, Olson L, Galter D. Association of a polymorphism in the ABCB1 gene with Parkinson's disease. Parkinsonism Relat Disord. 2009 Feb 2. PMID: 19196542.
  214. Estrela Rde C, Ribeiro FS, Barroso PF, Tuyama M, Gregório SP, Dias-Neto E, Struchiner CJ, Suarez-Kurtz G. ABCB1 polymorphisms and the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under antiretroviral therapy. Pharmacogenomics. 2009 Feb;10(2):311-8. PMID: 19207033.
  215. Oretti C, Marino S, Mosca F, Colnaghi MR, De Iudicibus S, Drigo I, Stocco G, Bartoli F, Decorti G, Demarini S. Glutathione-S-transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome. Eur J Clin Pharmacol. 2009 Jan 29. PMID: 19183974.
  216. Vahab SA, Sen S, Ravindran N, Mony S, Mathew A, Vijayan N, Nayak G, Bhaskaranand N, Banerjee M, Satyamoorthy K. Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population. Drug Metab Pharmacokinet. 2009;24(3):255-60. PMID: 19571437.
  217. Chen B, Fang J, Zhang W, Jin Z, Yu Z, Cai W. Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR. J Clin Lab Anal. 2009;23(2):110-6. PMID: 19288456.
  218. Krivulcik T, Sedlak J, Bartosova Z. Frequency of the three most common polymorphisms in the MDR1 gene in Slovak population. Neoplasma. 2009;56(2):101-7. PMID: 19239322.
  219. Krupoves A, Seidman EG, Mack D, Israel D, Morgan K, Lambrette P, Costea I, Deslandres C, Grimard G, Law L, Levy E, Amre DK. Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: A gene-wide study in a pediatric population. Inflamm Bowel Dis. 2008 Dec 23. PMID: 19107781.
  220. Jiang ZP, Xu P, Liu RR, Li HD, Wang GP, Zhao XL, Chen FP. Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjects. Pharmacogenomics. 2008 Dec;9(12):1801-8. PMID: 19072639.
  221. Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K. Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients. Transplantation. 2008 Nov 27;86(10):1379-83. PMID: 19034006.
  222. Bandur S, Petrasek J, Hribova P, Novotna E, Brabcova I, Viklicky O. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients. Transplantation. 2008 Nov 15;86(9):1206-13. PMID: 19005401.
  223. Juyal G, Midha V, Amre D, Sood A, Seidman E, Thelma BK. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians. Pharmacogenet Genomics. 2008 Nov 11. PMID: 19005421.
  224. Qiu XY, Jiao Z, Zhang M, Zhong LJ, Liang HQ, Ma CL, Zhang L, Zhong MK. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients. Eur J Clin Pharmacol. 2008 Nov;64(11):1069-84. PMID: 18636247.
  225. Gümü?-Akay G, Rüstemo?lu A, Karada? A, Sunguro?lu A. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population. Genet Mol Res. 2008 Oct 28;7(4):1193-9. PMID: 19048498.
  226. Wang Y, Wang C, Li J, Wang X, Zhu G, Chen X, Bi H, Huang M. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem. Eur J Clin Pharmacol. 2008 Oct 21. PMID: 18936931.
  227. Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Epilepsy Behav. 2008 Oct 7. PMID: 18812236.
  228. Singh R, Kesarwani P, Srivastava A, Mittal RD. ABCB1 G2677 allele is associated with high dose requirement of cyclosporin A to prevent renal allograft rejection in North India. Arch Med Res. 2008 Oct;39(7):695-701. PMID: 18760199.
  229. Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Habuchi T, Suzuki T. Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients. Steroids. 2008 Oct;73(11):1052-9. PMID: 18502461.
  230. Erdilyi DJ, Kámory E, Csókay B, Andrikovics H, Tordai A, Kiss C, Filni-Semsei A, Janszky I, Zalka A, Fekete G, Falus A, Kovács GT, Szalai C. Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy. Pharmacogenomics J. 2008 Oct;8(5):321-7. PMID: 17938643.
  231. Gonzalez TP, Mucenic T, Brenol JC, Xavier RM, Schiengold M, Chies JA. ABCB1 C1236T, G2677T/A and C3435T polymorphisms in systemic lupus erythematosus patients. Braz J Med Biol Res. 2008 Sep;41(9):769-72. PMID: 18820766.
  232. Frankfort SV, van Campen JP, Tulner LR, Beijnen JH. Serum amyloid beta peptides in patients with dementia and age-matched non-demented controls as detected by surface-enhanced laser desorption ionisation-time of flight mass spectrometry (SELDI-TOF MS). Curr Clin Pharmacol. 2008 Sep;3(3):144-54. PMID: 18781900.
  233. Johnatty SE, Beesley J, Paul J, Fereday S, Spurdle AB, Webb PM, Byth K, Marsh S, McLeod H, AOCS Study Group, Harnett PR, Brown R, DeFazio A, Chenevix-Trench G. ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clin Cancer Res. 2008 Sep 1;14(17):5594-601. PMID: 18765553.
  234. Alenius M, Wadelius M, Dahl ML, Hartvig P, Lindström L, Hammarlund-Udenaes M. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting. J Psychiatr Res. 2008 Sep;42(11):884-93. PMID: 18086475.
  235. Schaich M, Kestel L, Pfirrmann M, Robel K, Illmer T, Kramer M, Dill C, Ehninger G, Schackert G, Krex D. A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. Ann Oncol. 2008 Aug 7. PMID: 18687982.
  236. Zhang YT, Yang LP, Shao H, Li KX, Sun CH, Shi LW. ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients. Br J Clin Pharmacol. 2008 Aug;66(2):240-6. PMID: 18717915.
  237. Liu S, Beringer PM, Hidayat L, Rao AP, Louie S, Burckart GJ, Shapiro B. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. J Clin Pharmacol. 2008 Aug;48(8):957-65. PMID: 18511651.
  238. Zhang Y, Jiang XH, Hu YQ, Li ZR, Su L, Wang ZG, Ma G. MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males. Br J Clin Pharmacol. 2008 Aug;66(2):247-54. PMID: 18460034.
  239. Woodahl EL, Hingorani SR, Wang J, Guthrie KA, McDonald GB, Batchelder A, Li M, Schoch HG, McCune JS. Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation. Pharmacogenomics J. 2008 Aug;8(4):248-55. PMID: 17700595.
  240. Jamroziak K, Balcerczak E, Calka K, Piaskowski S, Urbanska-Rys H, Salagacka A, Mirowski M, Robak T. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma. Leuk Res. 2008 Jul 16. PMID: 18639335.
  241. Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, Dahut W, Sparreboom A, Figg WD. ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. Clin Cancer Res. 2008 Jul 15;14(14):4543-9. PMID: 18628469.
  242. Levran O, O'Hara K, Peles E, Li D, Barral S, Ray B, Borg L, Ott J, Adelson M, Kreek MJ. ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet. 2008 Jul 15;17(14):2219-27. PMID: 18424454.
  243. Takigawa N, Tanimoto M. [Vinca alkaloid and MDR1] Gan To Kagaku Ryoho. 2008 Jul;35(7):1086-9. PMID: 18633246.
  244. Hesselink DA, van Schaik RH, Nauta J, van Gelder T. A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine. Pharmacogenomics. 2008 Jun;9(6):783-9. PMID: 18518855.
  245. Gréen H, Söderkvist P, Rosenberg P, Horvath G, Peterson C. ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel. J Pharm Sci. 2008 Jun;97(6):2045-8. PMID: 17828752.
  246. Hung CC, Chen CC, Lin CJ, Liou HH. Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. PMID: 18408562.
  247. Gow JM, Hodges LM, Chinn LW, Kroetz DL. Substrate-dependent effects of human ABCB1 coding polymorphisms. J Pharmacol Exp Ther. 2008 May;325(2):435-42. PMID: 18287207.
  248. Lal S, Wong ZW, Sandanaraj E, Xiang X, Ang PC, Lee EJ, Chowbay B. Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients. Cancer Sci. 2008 Apr;99(4):816-23. PMID: 18377430.
  249. Crettol S, Venetz JP, Fontana M, Aubert JD, Ansermot N, Fathi M, Pascual M, Eap CB. Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients. Pharmacogenet Genomics. 2008 Apr;18(4):307-15. PMID: 18334915.
  250. Aarnoudse AJ, Dieleman JP, Visser LE, Arp PP, van der Heiden IP, van Schaik RH, Molokhia M, Hofman A, Uitterlinden AG, Stricker BH. Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration. Pharmacogenet Genomics. 2008 Apr;18(4):299-305. PMID: 18334914.
  251. Estrela RC, Ribeiro FS, Carvalho RS, Gregório SP, Dias-Neto E, Struchiner CJ, Suarez-Kurtz G. Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture. Pharmacogenomics. 2008 Mar;9(3):267-76. PMID: 18303963.
  252. Vaclavikova R, Nordgard SH, Alnaes GI, Hubackova M, Kubala E, Kodet R, Mrhalova M, Novotny J, Gut I, Kristensen VN, Soucek P. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients. Pharmacogenet Genomics. 2008 Mar;18(3):263-73. PMID: 18300948.
  253. Kato M, Fukuda T, Serretti A, Wakeno M, Okugawa G, Ikenaga Y, Hosoi Y, Takekita Y, Mandelli L, Azuma J, Kinoshita T. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):398-404. PMID: 17913323.
  254. Fanta S, Niemi M, Jönsson S, Karlsson MO, Holmberg C, Neuvonen PJ, Hoppu K, Backman JT. Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms. Pharmacogenet Genomics. 2008 Feb;18(2):77-90. PMID: 18192894.
  255. Wijnen PA, Op den Buijsch RA, Cheung SC, van der Heijden J, Hoogtanders K, Stolk LM, van Dieijen-Visser MP, Neef C, Drent M, Bekers O. Genotyping with a dried blood spot method: a useful technique for application in pharmacogenetics. Clin Chim Acta. 2008 Feb;388(1-2):189-91. PMID: 18028890.
  256. Xu P, Jiang ZP, Zhang BK, Tu JY, Li HD. Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers. Pharmacology. 2008;82(3):221-7. PMID: 18810246.
  257. Pel's IaR, Marusin AV, Spiridonova MG, Stepanov VA. [Polymorphism of human MDR1 gene in the Siberian and central Asian populations] Mol Biol (Mosk). 2007 Nov-Dec;41(6):982-8. PMID: 18318115.
  258. la Porte CJ, Li Y, Béïque L, Foster BC, Chauhan B, Garber GE, Cameron DW, van Heeswijk RP. The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir. Clin Pharmacol Ther. 2007 Oct;82(4):389-95. PMID: 17361121.
  259. Komar AA. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics. 2007 Aug;8(8):1075-80. PMID: 17716239.
  260. Jeannesson E, Albertini L, Siest G, Gomes AM, Ribeiro V, Aslanidis C, Schmitz G, Visvikis-Siest S. Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population. Fundam Clin Pharmacol. 2007 Aug;21(4):411-8. PMID: 17635180.
  261. Choi JH, Lee YJ, Jang SB, Lee JE, Kim KH, Park K. Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects. Br J Clin Pharmacol. 2007 Aug;64(2):185-91. PMID: 17391324.
  262. Oliveira E, Marsh S, van Booven DJ, Amorim A, Prata MJ, McLeod HL. Pharmacogenetically relevant polymorphisms in Portugal. Pharmacogenomics. 2007 Jul;8(7):703-12. PMID: 18240903.
  263. Han JY, Lim HS, Yoo YK, Shin ES, Park YH, Lee SY, Lee JE, Lee DH, Kim HT, Lee JS. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer. 2007 Jul 1;110(1):138-47. PMID: 17534875.
  264. Wu L, Xu X, Shen J, Xie H, Yu S, Liang T, Wang W, Shen Y, Zhang M, Zheng S. MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol. 2007 Jul 1;96(1):62-8. PMID: 17443726.
  265. Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1172-7. PMID: 17548681.
  266. Wang D, Ke XY, Wang J, Xu F, Hu YF. [Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia] Zhonghua Yi Xue Za Zhi. 2007 May 29;87(20):1384-8. PMID: 17785057.
  267. Schwarz UI, Hanso H, Oertel R, Miehlke S, Kuhlisch E, Glaeser H, Hitzl M, Dresser GK, Kim RB, Kirch W. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther. 2007 May;81(5):669-78. PMID: 17392718.
  268. Park HJ, Shinn HK, Ryu SH, Lee HS, Park CS, Kang JH. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clin Pharmacol Ther. 2007 Apr;81(4):539-46. PMID: 17192767.
  269. Li D, Zhang GL, Lou YQ, Li Q, Wang X, Bu XY. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. J Clin Pharm Ther. 2007 Feb;32(1):89-95. PMID: 17286792.
  270. Kimchi-Sarfaty C, Marple AH, Shinar S, Kimchi AM, Scavo D, Roma MI, Kim IW, Jones A, Arora M, Gribar J, Gurwitz D, Gottesman MM. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics. 2007 Jan;8(1):29-39. PMID: 17187507.
  271. Erdélyi DJ, Kámory E, Zalka A, Semsei AF, Csókay B, Andrikovics H, Tordai A, Borgulya G, Magyarosy E, Galántai I, Fekete G, Falus A, Szalai C, Kovács GT. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia. Cell Immunol. 2006 Dec;244(2):121-4. PMID: 17434155.
  272. van der Holt B, Van den Heuvel-Eibrink MM, Van Schaik RH, van der Heiden IP, Wiemer EA, Vossebeld PJ, Löwenberg B, Sonneveld P. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients. Clin Pharmacol Ther. 2006 Nov;80(5):427-39. PMID: 17112800.
  273. Haufroid V, Wallemacq P, VanKerckhove V, Elens L, De Meyer M, Eddour DC, Malaise J, Lison D, Mourad M. CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study. Am J Transplant. 2006 Nov;6(11):2706-13. PMID: 17049058.
  274. Xing Q, Gao R, Li H, Feng G, Xu M, Duan S, Meng J, Zhang A, Qin S, He L. Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics. 2006 Oct;7(7):987-93. PMID: 17054409.
  275. Bosch TM, Huitema AD, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JH. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel. Clin Cancer Res. 2006 Oct 1;12(19):5786-93. PMID: 17020985.
  276. Aarnoudse AL, van Schaik RH, Dieleman J, Molokhia M, van Riemsdijk MM, Ligthelm RJ, Overbosch D, van der Heiden IP, Stricker BH. MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine. Clin Pharmacol Ther. 2006 Oct;80(4):367-74. PMID: 17015054.
  277. Frankfort SV, Doodeman VD, Bakker R, Tulner LR, van Campen JP, Smits PH, Beijnen JH. ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients. Mol Neurodegener. 2006 Sep 25;113. PMID: 16999857.
  278. Takano A, Kusuhara H, Suhara T, Ieiri I, Morimoto T, Lee YJ, Maeda J, Ikoma Y, Ito H, Suzuki K, Sugiyama Y. Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil. J Nucl Med. 2006 Sep;47(9):1427-33. PMID: 16954549.
  279. Zamboni WC, Ramanathan RK, McLeod HL, Mani S, Potter DM, Strychor S, Maruca LJ, King CR, Jung LL, Parise RA, Egorin MJ, Davis TA, Marsh S. Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes. Invest New Drugs. 2006 Sep;24(5):393-401. PMID: 16505951.
  280. Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K, Nakagawa K. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics. 2006 Jun;7(4):551-61. PMID: 16753003.
  281. Komoto C, Nakamura T, Sakaeda T, Kroetz DL, Yamada T, Omatsu H, Koyama T, Okamura N, Miki I, Tamura T, Aoyama N, Kasuga M, Okumura K. MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab Pharmacokinet. 2006 Apr;21(2):126-32. PMID: 16702732.
  282. Osuga T, Sakaeda T, Nakamura T, Yamada T, Koyama T, Tamura T, Aoyama N, Okamura N, Kasuga M, Okumura K. MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese. Biol Pharm Bull. 2006 Feb;29(2):324-9. PMID: 16462040.
  283. Pechandová K, Buzková H, Slanar O, Perlík F. Polymorphisms of the MDR1 gene in the Czech population. Folia Biol (Praha). 2006;52(6):184-9. PMID: 17184596.
  284. Wang J, Zeevi A, McCurry K, Schuetz E, Zheng H, Iacono A, McDade K, Zaldonis D, Webber S, Watanabe RM, Burckart GJ. Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors. Transpl Immunol. 2006 Jan;15(3):235-40. PMID: 16431292.
  285. Fiegenbaum M, da Silveira FR, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH. The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clin Pharmacol Ther. 2005 Nov;78(5):551-8. PMID: 16321621.
  286. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics. 2005 Oct;15(10):693-704. PMID: 16141795.
  287. Zhang WX, Chen GL, Zhang W, Tan ZR, Liu J, Zhou G, Hu DL, Zhou HH. MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males. Clin Chim Acta. 2005 Sep;359(1-2):46-52. PMID: 16170863.
  288. Hung CC, Tai JJ, Lin CJ, Lee MJ, Liou HH. Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics. 2005 Jun;6(4):411-7. PMID: 16004559.
  289. Nakamura T, Sakaeda T, Takahashi M, Hashimoto K, Gemma N, Moriya Y, Komoto C, Nishiguchi K, Okamura N, Okumura K. Simultaneous determination of single nucleotide polymorphisms of MDR1 genes by electrochemical DNA chip. Drug Metab Pharmacokinet. 2005 Jun;20(3):219-25. PMID: 15988125.
  290. Schwarz UI, Seemann D, Oertel R, Miehlke S, Kuhlisch E, Fromm MF, Kim RB, Bailey DG, Kirch W. Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin Pharmacol Ther. 2005 Apr;77(4):291-301. PMID: 15903127.
  291. Allabi AC, Horsmans Y, Issaoui B, Gala JL. Single nucleotide polymorphisms of ABCB1 (MDR1) gene and distinct haplotype profile in a West Black African population. Eur J Clin Pharmacol. 2005 Apr;61(2):97-102. PMID: 15692830.
  292. Sunder-Plassmann R, Rieger S, Endler G, Brunner M, Müller M, Mannhalter C. Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCR. Clin Chem Lab Med. 2005;43(2):192-4. PMID: 15843215.
  293. Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, Clarke CL, Balleine RL, Gurney H. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clin Pharmacol Ther. 2005 Jan;77(1):33-42. PMID: 15637529.
  294. Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, Jung HR, Cho JY, Yu KS, Jang IJ, Shin SG. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Clin Pharmacol Ther. 2004 Nov;76(5):418-27. PMID: 15536457.
  295. Goreva OB, Grishanova AY, Domnikova NP, Mukhin OV, Lyakhovich VV. MDR1 Gene C1236T and C6+139T polymorphisms in the Russian population: associations with predisposition to lymphoproliferative diseases and drug resistance. Bull Exp Biol Med. 2004 Oct;138(4):404-6. PMID: 15665957.
  296. Wielandt AM, Vollrath V, Chianale J. [Polymorphisms of the multiple drug resistance gene (MDR1) in Mapuche, Mestizo and Maori populations in Chile] Rev Med Chil. 2004 Sep;132(9):1061-8. PMID: 15543762.
  297. Sparreboom A, Marsh S, Mathijssen RH, Verweij J, McLeod HL. Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients. Invest New Drugs. 2004 Aug;22(3):285-9. PMID: 15122075.
  298. Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Büchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther. 2004 May;75(5):422-33. PMID: 15116055.
  299. Haufroid V, Mourad M, Van Kerckhove V, Wawrzyniak J, De Meyer M, Eddour DC, Malaise J, Lison D, Squifflet JP, Wallemacq P. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Pharmacogenetics. 2004 Mar;14(3):147-54. PMID: 15167702.
  300. Sai K, Kaniwa N, Itoda M, Saito Y, Hasegawa R, Komamura K, Ueno K, Kamakura S, Kitakaze M, Shirao K, Minami H, Ohtsu A, Yoshida T, Saijo N, Kitamura Y, Kamatani N, Ozawa S, Sawada J. Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan. Pharmacogenetics. 2003 Dec;13(12):741-57. PMID: 14646693.
  301. Lötsch J, Skarke C, Geisslinger G. Simultaneous screening for three mutations in the ABCB1 gene. Genomics. 2003 Nov;82(5):503-10. PMID: 14559207.
  302. Mathijssen RH, Marsh S, Karlsson MO, Xie R, Baker SD, Verweij J, Sparreboom A, McLeod HL. Irinotecan pathway genotype analysis to predict pharmacokinetics. Clin Cancer Res. 2003 Aug 15;9(9):3246-53. PMID: 12960109.
  303. Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B, Beaune P, Legendre C, Thervet E. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol. 2003 Jul;14(7):1889-96. PMID: 12819250.
  304. Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS, Lee CG. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics. 2002 Aug;12(6):437-50. PMID: 12172212.
  305. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther. 2001 Aug;70(2):189-99. PMID: 11503014.